Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously reported that prolactin (PRL) could increase the activity of
ornithine decarboxylase
(
ODC
) in liver slices taken from larval tiger salamanders (Ambystoma tigrinum). This action of the hormone was inhibited by
oxytocin
(OT), the calcium ionophore A23187, and diacyglycerol (DG) and was duplicated by 10 microM verapamil (VML), a calcium channel blocker. Here, we expand these results to show that 1) a higher dose of VML (50 microM) produces an additive effect with PRL; 2) addition of small amounts of calcium (0.1 mM) to the liver culture medium blocks PRL action; 3) neither nifedipine (NIF), a different type of calcium channel blocker, nor EDTA alter PRL action; and 4) gossypol, a reported inhibitor of protein kinase C, mimics PRL action. Additionally, we show that PRL increases
ODC
activity in tiger salamander tail skin in vitro, a tissue previously demonstrated to be a PRL target tissue in this species. The same set of treatments which we have shown to modify PRL effects on
ODC
in liver slices affects PRL action in the tail skin in a parallel manner. Thus, the mechanism whereby PRL enhances
ODC
activity appears to be the same in both these tissues. These results are discussed in conjunction with the findings from similar studies using mammalian tissues in an attempt to assess the current picture of the mechanism of PRL action and the possible role of inositol phospholipid turnover, calcium, and protein kinase C in the action of this hormone.
...
PMID:Reduced calcium and inhibition of protein kinase C mimic the enhancement of ornithine decarboxylase activity of prolactin in Ambystoma tigrinum tissues. 194 Aug 22
Prolactin has been shown to increase the activity of
ornithine decarboxylase
in a variety of mammalian tissues and in the pigeon crop sac. This study demonstrates a similar effect of ovine prolactin on
ornithine decarboxylase
activity in liver slices taken from larval tiger salamanders (Ambystoma tigrinum). An evaluation of potential mediators of prolactin action in liver slices revealed that the effect of the hormone on enzyme activity was not blocked by ouabain, an inhibitor of the sodium pump reported to block other actions of prolactin.
Oxytocin
, which inhibits prolactin actions in A. tigrinum, blocked the increase in
ornithine decarboxylase
activity induced by prolactin. Since previous results had implicated inositol phospholipid turnover in
oxytocin
action, the effects of the calcium ionophore, A 23187, and of synthetic diacylglycerol were examined. Both agents blocked the increase in enzyme activity when they were combined with prolactin treatment. Verapamil, a calcium channel blocker, had a prolactin-like effect on the activity of
ornithine decarboxylase
, and the combination of prolactin and verapamil produced a stimulation of the enzyme that was no greater than that observed with either the drug or prolactin alone, suggesting that both agents might be acting via a common cellular pathway. The tentative hypothesis that prolactin acts via a mechanism which lowers intracellular calcium is suggested.
...
PMID:Enhancement of ornithine decarboxylase activity in Ambystoma liver slices by ovine prolactin: an evaluation of possible mediators. 314 Dec 45
The nonsteroidal anti-inflammatory drug (NSAID) sulindac and the
ornithine decarboxylase
(
ODC
) antagonist difluoromethylornithine (DFMO), individually and together, are effective inhibitors of colon carcinogenesis. However, chronic use of sulindac is associated with significant side effects. We evaluated the chemopreventive efficacy of phospho-sulindac (P-S,
OXT
-328), an apparently safe derivative of sulindac, together with DFMO, in HT-29 human colon cancer xenografts. Nude mice were divided into four groups as follows: group 1 received vehicle (corn oil); group 2 received P-S (100 mg/kg/d) by oral gavage; group 3 received DFMO (2% in drinking water); and group 4 received P-S (100 mg/kg/d) by gavage plus DFMO (2% in drinking water; P-S/DFMO). Eighteen days after implantation, compared with controls, tumor volume was inhibited 65.9% by P-S, 52.9% by DFMO, and 70.9% by P-S/DFMO (P < 0.01 for all). P-S/DFMO reduced cell proliferation 27.1% and increased apoptosis 38.9% compared with controls (P < 0.05 for both). Compared with controls, P-S reduced the levels of thioredoxin-1 (Trx-1) and thioredoxin reductase (TrxR), whereas DFMO reduced polyamine content (putrescine and spermidine) and TrxR levels. Importantly, P-S/DFMO decreased putrescine and spermidine levels and the expression of Trx-1, TrxR, and cyclooxygenase (COX) 2. Of these molecular targets, TrxR most consistently correlated with tumor growth. Study results show that P-S/DFMO is an efficacious drug combination for colon cancer prevention and also show the safety of P-S, which may overcome the limiting side effects of conventional sulindac. P-S/DFMO has an intricate mechanism of action extending beyond polyamines and including the thioredoxin system, an emerging regulator of chemoprevention. P-S/DFMO merits further evaluation.
...
PMID:Phospho-sulindac (OXT-328) combined with difluoromethylornithine prevents colon cancer in mice. 2146 38
The polyamines spermidine and spermine are small cations present in all living cells. In the brain, these cations are particularly abundant in the neurons of the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus, which synthesize the neuropeptide hormones arginine vasopressin (AVP) and
oxytocin
. We recently reported increased mRNA expression of antizyme inhibitor 1 (Azin1), an important regulator of polyamine synthesis, in rat SON and PVN as a consequence of 3 days of dehydration. Here we show that AZIN1 protein is highly expressed in both AVP- and
oxytocin
-positive magnocellular neurons of the SON and PVN together with antizyme 1 (AZ1),
ornithine decarboxylase
, and polyamines. Azin1 mRNA expression increased in the SON and PVN as a consequence of dehydration, salt loading, and acute hypertonic stress. In organotypic hypothalamic cultures, addition of the irreversible
ornithine decarboxylase
inhibitor DL-2-(difluoromethyl)-ornithine hydrochloride significantly increased the abundance of heteronuclear AVP but not heteronuclear
oxytocin
. To identify the function of Azin1 in vivo, lentiviral vectors that either overexpress or knock down Azin1 were stereotaxically delivered into the SON and/or PVN. Azin1 short hairpin RNA delivery resulted in decreased plasma osmolality and had a significant effect on food intake. The expression of AVP mRNA was also significantly increased in the SON by Azin1 short hairpin RNA. In contrast, Azin1 overexpression in the SON decreased AVP mRNA expression. We have therefore identified AZIN1, and hence by inference, polyamines as novel regulators of the expression of the AVP gene.
...
PMID:Control of Polyamine Biosynthesis by Antizyme Inhibitor 1 Is Important for Transcriptional Regulation of Arginine Vasopressin in the Male Rat Hypothalamus. 2618 58